Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million.

GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & ...

If you're looking to shake things up in the new year, these streaming platforms will help you diversify your music-listening ...

Trying to impress a tween with the perfect gift? From trendy fashion accessories to stylish home décor, we curated a ...

During development of the digestive system, a complex network of nerves forms around it, creating a "second brain" — the enteric nervous system (ENS) — which controls the movement of food and waste ...

Officials said progress is being made in identifying a person of "significant interest" who has now been seen in several ...